ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity Journal Article


Authors: Moore, M. J.; Blachere, N. E.; Fak, J. J.; Park, C. Y.; Sawicka, K.; Parveen, S.; Zucker-Scharff, I.; Moltedo, B.; Rudensky, A. Y.; Darnell, R. B.
Article Title: ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity
Abstract: Dynamic post-transcriptional control of RNA expression by RNA-binding proteins (RBPs) is critical during immune response. ZFP36 RBPs are prominent inflammatory regulators linked to autoimmunity and cancer, but functions in adaptive immunity are less clear. We used HITS-CLIP to define ZFP36 targets in mouse T cells, revealing unanticipated actions in regulating T-cell activation, proliferation, and effector functions. Transcriptome and ribosome profiling showed that ZFP36 represses mRNA target abundance and translation, notably through novel AU-rich sites in coding sequence. Functional studies revealed that ZFP36 regulates early T-cell activation kinetics cell autonomously, by attenuating activation marker expression, limiting T cell expansion, and promoting apoptosis. Strikingly, loss of ZFP36 in vivo accelerated T cell responses to acute viral infection and enhanced anti-viral immunity. These findings uncover a critical role for ZFP36 RBPs in restraining T cell expansion and effector functions, and suggest ZFP36 inhibition as a strategy to enhance immune-based therapies. © Moore et al.
Journal Title: eLife
Volume: 7
ISSN: 2050-084X
Publisher: eLife Sciences Publications Ltd.  
Date Published: 2018-05-31
Start Page: e33057
Language: English
DOI: 10.7554/eLife.33057
PROVIDER: scopus
PMCID: PMC6033538
PUBMED: 29848443
DOI/URL:
Notes: Article -- Export Date: 4 September 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Rudensky
    156 Rudensky